Protara Therapeutics, Inc.
NASDAQ: TARA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jesse Shefferman
- Employees
- 28
- Headquarters
- New York City, United States
- IPO year
- 2014
- Market cap
- $155.5M
- Website
- https://www.protaratx.com
Loading TARA…
Loading profile data…Frequently asked questions about TARA
What does Protara Therapeutics, Inc. (TARA) do?
Protara Therapeutics, Inc. is a biotechnology company actively involved in clinical research and development, striving to identify and advance groundbreaking therapies. Their core mission is to tackle significant medical challenges in both oncology and rare disease domains. The company's leading therapeutic candidate, TARA-002, is an investigati...
Where does TARA trade?
Protara Therapeutics, Inc. (TARA) trades on the NASDAQ Global Market.
What sector is TARA in?
Protara Therapeutics, Inc. (TARA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Protara Therapeutics, Inc.?
Jesse Shefferman is the chief executive officer of Protara Therapeutics, Inc. (TARA).
Where is Protara Therapeutics, Inc. headquartered?
Protara Therapeutics, Inc. is headquartered in United States.
Does TARA pay a dividend?
Protara Therapeutics, Inc. (TARA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TARA go public?
Protara Therapeutics, Inc. (TARA) completed its initial public offering in 2014.